查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1611260

2025-2030年美國血管通路裝置市場規模、佔有率、按產品分類的趨勢分析報告、按細分市場預測

U.S. Vascular Access Devices Market Size, Share & Trends Analysis Report By Product (Central Venous Catheters (CVC), Peripherally Inserted Central Catheter (PICCs)), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 105 Pages | 商品交期: 2-10個工作天內

價格

美國靜脈通路裝置市場趨勢

預計 2024 年美國靜脈通路裝置市場規模將達到 14 億美元，2025 年至 2030 年複合年成長率預計為 5.6%。

慢性病盛行率的不斷上升以及對需要血管通路的醫療程序的需求不斷成長推動了市場的成長。隨著醫療保健提供者不斷尋求有效的解決方案來輸送藥物、液體和營養物質，對創新靜脈通路裝置的需求預計將會增加。此外，抗菌塗層的開發以及將智慧技術整合到血管通路裝置等技術進步有助於提高患者安全性和改善臨床結果。

美國心血管疾病患者數量的增加預計將推動市場成長。根據美國心臟協會 2024 年 1 月發表的論文，CVD 在美國每天造成約 2,552 人死亡。 CVD 患者需要長期治療，包括藥物和液體治療，通常透過中央靜脈導管(CVC) 和周邊置入中央靜脈導管(PICC) 等靜脈通路裝置進行治療。對心血管治療的需求不斷成長是市場的主要驅動力，因為這些設備在有效管理心血管疾病方面發揮關鍵作用。

美國靜脈通路裝置產業的成長也受到兒科患者擴大使用靜脈通路裝置的推動。例如，人口研究實驗室在2024年1月預測，美國65歲以上人口數將從2022年的5,800萬增加到2050年的8,200萬，增加47%。此外，該年齡層人口占總人口的比例預計將從17%增加到23%。老年人更容易受到感染疾病，需要住院接受腸外營養 (PN) 治療以維持體力、能量和水分。

此外，癌症患者數量的增加和對化療的需求預計將推動市場成長。據美國國家癌症美國稱，2024 年美國將診斷出約 2,001,140 例新癌症病例，預計將有 611,720 人死於該疾病。癌症治療，尤其是化療，在控制癌症方面發揮重要作用。根據健康成本研究所 2023 年 3 月發表的報導，美國每年有近 100 萬人接受化療。大多數這些治療是透過靜脈注射或注射進行的，通常需要患者去醫生檢查室或醫院門診診所。

輸液療法在癌症治療中的廣泛使用凸顯了靜脈通路裝置（例如周邊置入中央靜脈導管（PICC）和中央靜脈導管（CVC））在化療中的重要作用。這是因為這些設備對於確保接受治療的癌症患者安全、有效且長期進入血液至關重要。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章美國靜脈通路裝置市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國靜脈通路裝置市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 管道分析

第4章美國靜脈通路裝置市場：依產品估算與趨勢分析

  • 美國靜脈通路裝置市場：產品儀表板
  • 美國靜脈通路裝置市場：產品變化分析
  • 美國靜脈通路裝置市場（按產品、按收益）
  • 中央靜脈導管（CVC）
    • 隧道CVC
    • 非隧道CVC
  • 周邊靜脈營養（PPN）
    • 高功能性
    • 標準

第5章競爭狀況

  • 主要製造商的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 2024年主要企業市場佔有率分析
  • 公司簡介
    • BD
    • Teleflex
    • B Braun
    • Medical Components, Inc
    • Vygon SA
    • Medtronic/Mozarc Medical
    • Merit Medical/AngioDynamics
    • 其他
Product Code: GVR-4-68040-493-3

U.S. Vascular Access Devices Market Trends:

The U.S. vascular access devices market size was estimated at USD 1.40 billion in 2024 and is expected to grow at a CAGR of 5.6% from 2025 to 2030. The market growth is driven by the increasing prevalence of chronic diseases and the growing need for medical procedures that require vascular access. As healthcare providers continue to seek efficient solutions for delivering medications, fluids, and nutrients, the demand for innovative vascular access devices is expected to rise. Additionally, advancements in technology, such as the development of antimicrobial coatings and the integration of smart technologies in vascular access devices, contribute to enhancing patient safety and improving clinical outcomes.

The rising CVD cases in the U.S. are expected to fuel the market growth. According to the American Heart Association article published in January 2024, in the U.S., CVD results in about 2,552 deaths each day. CVD patients require long-term treatments involving medications and fluids, often administered through vascular access devices like central venous catheters (CVCs) and peripherally inserted central catheters (PICCs). This growing demand for cardiovascular care is a key driver for the market, as these devices play a critical role in managing CVD effectively

The growth of the U.S. vascular access devices industry is also driven by rising use of vascular access devices among pediatric patients. For instance, in January 2024, the Population Reference Bureau had projected that the American population aged 65 and over would expand from 58 million in 2022 to 82 million by 2050, reflecting a 47% increase. Additionally, it was anticipated that the share of the total population belonging to this age bracket would grow from 17% to 23%. Older adults are easily susceptible to infectious diseases and need hospital treatment by administering parenteral nutrition (PN), which helps maintain strength, energy, and hydration.

In addition, increased cancer cases and chemotherapy demand is anticipated to drive the growth of the market. According to the National Cancer Institute, in 2024, it is projected that approximately 2,001,140 new cancer cases will be diagnosed in the United States, with an estimated 611,720 individuals expected to die from the disease. Cancer treatment, particularly chemotherapy, plays a crucial role in managing the condition. According to a Health Cost Institute article published in March 2023, nearly 1 million people in the U.S. undergo chemotherapy each year. Most of these treatments are administered via infusion or injection, often requiring patients to visit a physician's office or hospital outpatient department.

The widespread use of infusion therapies in cancer treatment underscores the critical role of vascular access devices, such as peripherally inserted central catheters (PICCs) and central venous catheters (CVCs), in delivering chemotherapy. This growing demand for oncology care is drives the North American vascular access devices market, as these devices are essential for ensuring safe, effective, and long-term access to the bloodstream for cancer patients undergoing treatment.

U.S. Vascular Access Devices Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. vascular access devices market report based on product:

  • Product Outlook (Revenue, USD Billion, 2018 - 2030)
  • Central Venous Catheters (CVC)
    • Tunneled CVC
    • Non-Tunneled CVC
  • Peripherally Inserted Central Catheter (PICCs)
    • Power Injected
    • Standard

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Vascular Access Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing prevalence of cardiovascular diseases
      • 3.2.1.2. Increasing need for vascular access devices in oncology
      • 3.2.1.3. Technological advancements in vascular access devices
      • 3.2.1.4. Rising use of vascular access devices among pediatric patients
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations and product recalls
      • 3.2.2.2. Risks associated with catheter usage
  • 3.3. U.S. Vascular Access Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pipeline Analysis

Chapter 4. U.S. Vascular Access Devices Market: Product Estimates & Trend Analysis

  • 4.1. Global U.S. Vascular Access Devices Market: Product Dashboard
  • 4.2. Global U.S. Vascular Access Devices Market: Product Movement Analysis
  • 4.3. Global U.S. Vascular Access Devices Market by Product, Revenue
  • 4.4. Central Venous Catheters (CVC)
    • 4.4.1. Central Venous Catheters (CVC) market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.2. Tunneled CVC
      • 4.4.2.1. Tunneled CVC market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.3. Non-Tunneled CVC
      • 4.4.3.1. Tunneled CV market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5. Peripheral Parenteral Nutrition (PPN)
    • 4.5.1. Peripheral parenteral nutrition (PPN) market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.2. Power Injected
      • 4.5.2.1. Power Injected market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.3. Standard
      • 4.5.3.1. Standard market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Competitive Landscape

  • 5.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 5.2. Company/Competition Categorization
  • 5.3. Vendor Landscape
    • 5.3.1. List of key distributors and channel partners
    • 5.3.2. Key customers
    • 5.3.3. Key company market share analysis, 2024
  • 5.4. Company Profiles
    • 5.4.1. BD
      • 5.4.1.1. Company overview
      • 5.4.1.2. Financial performance
      • 5.4.1.3. Product benchmarking
      • 5.4.1.4. Strategic initiatives
    • 5.4.2. Teleflex
      • 5.4.2.1. Company overview
      • 5.4.2.2. Financial performance
      • 5.4.2.3. Product benchmarking
      • 5.4.2.4. Strategic initiatives
    • 5.4.3. B Braun
      • 5.4.3.1. Company overview
      • 5.4.3.2. Financial performance
      • 5.4.3.3. Product benchmarking
      • 5.4.3.4. Strategic initiatives
    • 5.4.4. Medical Components, Inc
      • 5.4.4.1. Company overview
      • 5.4.4.2. Financial performance
      • 5.4.4.3. Product benchmarking
      • 5.4.4.4. Strategic initiatives
    • 5.4.5. Vygon SA
      • 5.4.5.1. Company overview
      • 5.4.5.2. Financial performance
      • 5.4.5.3. Product benchmarking
      • 5.4.5.4. Strategic initiatives
    • 5.4.6. Medtronic/Mozarc Medical
      • 5.4.6.1. Company overview
      • 5.4.6.2. Financial performance
      • 5.4.6.3. Product benchmarking
      • 5.4.6.4. Strategic initiatives
    • 5.4.7. Merit Medical/AngioDynamics
      • 5.4.7.1. Company overview
      • 5.4.7.2. Financial performance
      • 5.4.7.3. Product benchmarking
      • 5.4.7.4. Strategic initiatives
    • 5.4.8. Others
      • 5.4.8.1. Company overview
      • 5.4.8.2. Financial performance
      • 5.4.8.3. Product benchmarking
      • 5.4.8.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. vascular access devices market, by product, 2018 - 2030 (USD Billion)
  • Table 3 Participant's overview
  • Table 4 Financial performance
  • Table 5 Key companies undergoing expansions
  • Table 6 Key companies undergoing acquisitions
  • Table 7 Key companies undergoing collaborations
  • Table 8 Key companies launching new products
  • Table 9 Key companies undergoing partnerships
  • Table 10 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 U.S. vascular access devices market: market outlook
  • Fig. 8 U.S. vascular access devices competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 U.S. vascular access devices market driver impact
  • Fig. 13 U.S. vascular access devices market restraint impact
  • Fig. 14 U.S. vascular access devices: Product movement analysis
  • Fig. 15 U.S. vascular access devices: Product outlook and key takeaways
  • Fig. 16 Central Venous Catheters (CVC) market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 17 Tunneled CVC market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 18 Non-Tunneled CVC market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 19 Peripherally Inserted Central Catheter (PICCs) market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 20 Power Injected market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 21 Standard market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 22 Key company categorization
  • Fig. 23 Strategy mapping